MyFinsight
Home
Blog
About
Contact
Download
Download image
Cash and cash
equivalents
$14,599,347
Prepaid expenses and
other current assets
$961,899
Total current assets
$15,561,246
Other noncurrent
assets
$271,162
Property and equipment,
net
$59,807
Restricted cash
$41,186
Total assets
$15,933,401
Total liabilities and
stockholders' equity
$15,933,401
Total stockholders'
equity
$12,441,682
Total current
liabilities
$2,764,358
Series a convertible
preferred stock, 0.001 par...
$727,361
Accumulated deficit
-$333,641,441
Accumulated other
comprehensive loss
-$10,634,714
Additional paid-in capital
$356,709,645
Accrued expenses
$2,050,690
Accounts payable
$713,668
Common stock, 0.001 par
value, 400,000,000...
$8,192
Back
Back
Balance Sheet
source: myfinsight.com
Aprea Therapeutics, Inc. (APRE)
Aprea Therapeutics, Inc. (APRE)